Quest Diagnostics SVP sells 8,147 shares at $200
Quest Diagnostics senior vice president Karthik Kuppusamy exercised stock options and sold shares in a pre-planned trade.
Rhea-AI Filing Summary
Quest Diagnostics senior vice president Karthik Kuppusamy exercised stock options and sold shares in a pre-planned trade. On 2026-06-04, he exercised options for 4,827 shares at $121.805 per share and 3,320 shares at $127.725, acquiring 8,147 shares of common stock through derivative exercises.
That same day, he completed an open-market sale of 8,147 common shares at $200.00 per share pursuant to a Rule 10b5-1 sales plan, converting option value into cash in a pre-arranged manner. Following these transactions, he directly held 13,510 common shares, with additional indirect holdings of 358 shares in a trust and 1,721 shares through the company’s 401(k) profit sharing plan.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualifed Stock Option (right to buy) | 3,320 | $127.725 | $424K |
| Exercise | Non-Qualifed Stock Option (right to buy) | 4,827 | $121.805 | $588K |
| Exercise | Common Stock | 3,320 | $127.725 | $424K |
| Exercise | Common Stock | 4,827 | $121.805 | $588K |
| Sale | Common Stock | 8,147 | $200.00 | $1.63M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (5)
- F1. This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
- F2. The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
- F3. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
- F4. The options vested in three annual installments beginning with the first on February 24, 2023, the second on February 24, 2024 and the final on February 24, 2025.
- F5. The options vested in three annual installments beginning with the first on February 17, 2022, the second on February 17, 2023 and the final on February 17, 2024.
Key Figures
Key Terms
Rule 10b5-1 sales plan regulatory
Non-Qualifed Stock Option (right to buy) financial
Profit Sharing (401(k)) Plan financial
open-market sale financial
derivative exercise/conversion financial
AI-generated analysis. How Rhea-AI works. Not financial advice.